Anthony Culverwell
Directeur/Bestuurslid bij TC BIOPHARM (HOLDINGS) PLC
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Anthony Culverwell
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.
20
| Subsidiary | Pharmaceuticals: Major | 20 |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland.
11
| Extinct | Pharmaceuticals: Major | 11 |
| Unknown | 9 | ||
| Holding Company | Pharmaceuticals: Major | 9 | |
| Unknown | 7 | ||
Safeguard Biosystems Holdings Ltd.
 Safeguard Biosystems Holdings Ltd. Medical SpecialtiesHealth Technology Safeguard Biosystems Holdings Ltd. engages in the development, manufacture, and sales of diagnostic tests for human and animal health; and food safety products. The company was founded on May 11, 2006 and is headquartered in London, the United Kingdom.
5
| Private Company | Medical Specialties | 5 |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Sudbrook Associates LLP
1
| Private Company | 1 | |
Hox Therapeutics Ltd.
 Hox Therapeutics Ltd. BiotechnologyHealth Technology Hox Therapeutics Ltd. develops therapeutics for cancer diseases based on the role of HOX genes. The private company is based in Guildford, UK.
1
| Private Company | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Anthony Culverwell via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Tech/Sci/R&D Officer President | |
U.S. Bioscience, Inc.
 U.S. Bioscience, Inc. BiotechnologyHealth Technology U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
Fuisz Technologies Ltd.
 Fuisz Technologies Ltd. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Fuisz Technologies Ltd. is a company that develops and commercializes rapid dissolving tablets for over-the-counter and prescription pharmaceuticals. The company is based in Chantilly, VA. Fuisz Technologies was acquired by Biovail Corp. on November 12, 1999 for $145.48 million. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| WEST PHARMACEUTICAL SERVICES, INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Micreos BV
 Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Pharmaceuticals: Generic | Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
| The University of Chicago | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Franklin & Marshall College | College/University | Undergraduate Degree Undergraduate Degree | |
American Bar Association
 American Bar Association Miscellaneous Commercial ServicesCommercial Services American Bar Association provides legal services. It provides law school accreditation, continuing legal education, legal information and other services to assist legal professionals. The firm has members which include judges, court administrators, law professors, and non-practicing attorneys. The company was founded on August 21, 1878 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
The Beekman Group LLC
 The Beekman Group LLC Investment ManagersFinance The Beekman Group LLC (The Beekman Group) is a private equity firm founded in 2004 by Andrew V. Marolda and John G. Troiano. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Chairman | |
| ARCH BIOPARTNERS INC. | Pharmaceuticals: Major | Director/Board Member | |
| INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| CIRCIO HOLDING ASA | Biotechnology | Chairman | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Consilient Health Ltd.
 Consilient Health Ltd. Pharmaceuticals: MajorHealth Technology Consilient Health Ltd. engages in the manufacture and distribution of pharmaceuticals. The private company is based in Clonskea, Ireland, and has subsidiaries in the United Kingdom. Luke Crosbie has been the CEO of the Irish company since 2005. | Pharmaceuticals: Major | Director/Board Member | |
Innocoll Pharmaceuticals Ltd.
 Innocoll Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Innocoll Pharmaceuticals Ltd. engages in pharmaceutical preparations. The company was founded on June 1, 2005 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Director/Board Member | |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Chairman | |
| ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Chairman | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member Director of Finance/CFO | |
TC Biopharm Ltd.
 TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Founder Chief Executive Officer | |
Amryt Pharmaceuticals DAC
 Amryt Pharmaceuticals DAC Pharmaceuticals: MajorHealth Technology Amryt Pharmaceuticals DAC manufactures pharmaceutical products. The company was founded on August 19, 2015 and is headquartered in Ballsbridge, Ireland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Berg LLC
 Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
| Sonoran Biosciences, Inc. | Director/Board Member Director/Board Member | ||
Quoin Pharmaceuticals, Inc.
 Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Director/Board Member | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Chairman Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member General Counsel General Counsel Public Communications Contact Human Resources Officer Corporate Officer/Principal | |
| POOLBEG PHARMA PLC | Pharmaceuticals: Major | Founder Corporate Officer/Principal General Counsel | |
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Founder Corporate Officer/Principal Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 27 |
| Verenigd Koninkrijk | 10 |
| Ierland | 6 |
| Zwitserland | 5 |
| Nederland | 2 |
Sectoraal
| Health Technology | 40 |
| Consumer Services | 5 |
| Commercial Services | 4 |
| Finance | 3 |
Operationeel
| Director/Board Member | 279 |
| Corporate Officer/Principal | 142 |
| Independent Dir/Board Member | 83 |
| Chairman | 80 |
| Chief Executive Officer | 56 |
Sterkste connecties
| Insiders | |
|---|---|
| Dennis Langer | 40 |
| Alain Munoz | 38 |
| Patrick Volkert Vink | 30 |
| Arlene Morris | 28 |
| Anthony Zook | 24 |
| Jonathan Symonds | 24 |
| Shumeet Banerji | 23 |
| Stephen Wills | 22 |
| Tony H. Wild | 22 |
| Arthur Harold Rubenstein | 20 |
| Lesley Russell | 19 |
| David Brennan | 19 |
| James Tursi | 17 |
| Harry Thomas Stratford | 16 |
| Michael Sember | 16 |
- Beurs
- Insiders
- Anthony Culverwell
- Bedrijfsconnecties
